omi stock guide: Owens & Minor to Accendra

OMI (Owens & Minor, Inc. / Accendra Health, Inc.)

Keyword in context: This article covers omi stock as the NYSE equity historically trading under the ticker OMI and the company's repositioning toward Accendra Health (new ticker ACH). The content is aimed at investors and researchers seeking a clear, neutral, and up-to-date reference on the company, its corporate history, recent transactions, and market information.

Company overview

omi stock refers to Owens & Minor, Inc., a U.S.-based healthcare logistics, distribution and home-based care provider that historically traded under the ticker OMI on the New York Stock Exchange and has undergone a strategic repositioning and corporate rename to Accendra Health, Inc. The company operates supply-chain and distribution services for medical and surgical supplies and provides patient-direct home health and durable medical equipment services under brands such as Apria and Byram. Its operations span the United States with additional international logistics capabilities.

As of the latest corporate communications and market data cited below, omi stock represents a company focused on shifting capital and management attention from its larger distribution products business toward patient-directed home health services and related care capabilities.

Corporate history

Founding and early history

Owens & Minor traces its roots to the late 19th century. Founded in 1882, the company evolved from a regional distributor of medical and surgical supplies into a national healthcare logistics and distribution firm. Over decades, the firm expanded its product lines, built warehousing and distribution networks, and developed specialized logistics services for hospitals, surgery centers, and other healthcare providers.

Major growth milestones and acquisitions

Throughout the late 20th and early 21st centuries, Owens & Minor grew through a combination of organic expansion and acquisitions. Key strategic moves included the acquisition of regional distributors and investments in logistics technologies to support inventory management, kitting and just-in-time supply for health systems. In more recent history, the addition of patient-direct home health and durable medical equipment capabilities — notably the Apria brand — positioned the company to serve both institutional and consumer-facing care channels.

As omi stock investors have observed, the company’s M&A and portfolio decisions were intended to diversify revenue streams across Products & Healthcare Services (P&HS) distribution and Patient Direct home-health operations; this dual exposure shaped investor perceptions of growth and risk for the equity.

Recent transformation and rebranding

In response to strategic reviews and changing healthcare demand, Owens & Minor announced a transaction to divest its Products & Healthcare Services (P&HS) segment and pursue a narrower, growth-focused strategy on home-based care services. As part of this repositioning, the company declared a corporate name and ticker change to Accendra Health, Inc. to better reflect its new business mix and strategic priorities.

As of January 2026, per public filings and company press releases, the divestiture and rebranding process have advanced through signed agreements and regulatory filings. Shareholders and market participants should monitor company 8-K filings and investor presentations for closing dates and the official effective date of the ticker change (expected to take effect after required regulatory and shareholder approvals).

Business segments and operations

Historically, Owens & Minor reported two primary operating segments that helped define omi stock’s business profile:

• Products & Healthcare Services (P&HS): a broad distribution business supplying medical and surgical products, PPE, and facility supplies to hospitals, health systems, and ambulatory centers. This segment included logistics, inventory management and supply-chain services for institutional customers.

• Patient Direct: consumer-facing home health and durable medical equipment (DME) services, including respiratory care, mobility aids, and in-home clinical support. Brands such as Apria and Byram have been associated with this segment.

Following the announced divestiture of P&HS, Accendra Health is positioning itself as a more concentrated home-based care and patient-direct services provider. Core offerings in the restructured company include outsourced logistics for home-health deliveries, durable medical equipment provisioning, remote monitoring integration partnerships, kitting and device management, and care coordination services that connect clinicians with patients in their homes.

Major transactions and restructuring

A defining recent event for omi stock was the sale/transfer of the P&HS segment to a private equity buyer as part of a portfolio simplification strategy. The transaction included a cash consideration component, retention of certain equity rights by the parent for contingent value or roll participation, and specific tax attribute preservation measures designed to benefit continuing shareholders where applicable.

As of January 2026, per company disclosures and coverage in financial press, the strategic rationale presented by management emphasized:

• Simplifying the corporate structure to create a focused home-health platform (the future Accendra Health).
• Unlocking value from the large-scale P&HS distribution business through monetization to an experienced investor in the healthcare distribution sector.
• Strengthening the balance sheet and providing capital to invest in Patient Direct growth initiatives, including technology and clinical program expansion.

Investors tracking omi stock should note that such transactions typically affect revenue composition, working capital dynamics and reported margins. The sell-down of a large distribution business often reduces revenue but can improve margin profile and capital allocation flexibility for the remaining business.

Financial information

Key financials

omi stock historically reflected a company with multi-billion-dollar revenue at the consolidated level when both distribution and patient-direct businesses were combined. Post-transaction, Accendra Health’s pro forma revenue base will primarily reflect Patient Direct operations, which typically have lower nominal revenue but higher recurring-service exposure and different margin characteristics.

As of the most recent quarter-end filings, the company reported sequential trends showing pressure on distribution volumes partly due to industry-wide purchasing normalization and inventory destocking, while patient-direct demand for DME and home-health services remained stable. For exact figures on recent revenue, net income or adjusted EBITDA, investors should consult the company’s latest 10-Q and investor presentation filed with the SEC.

Historical stock performance

omi stock’s price history saw notable volatility around corporate announcements, earnings results and macro healthcare events. Over multi-year horizons, the stock experienced wide trading ranges influenced by margin pressure in distribution, large restructuring charges and investor reactions to M&A outcomes. Significant one-day price moves were typically associated with transaction announcements or quarterly releases that revised guidance materially.

Dividends, capital structure and credit

Prior to the strategic shift, Owens & Minor maintained a conservative approach to regular cash returns, focusing capital on operations and strategic investments. The company has used a combination of cash on hand and long-term debt to fund operations and acquisitions historically. Credit events, including debt issuance for refinancing or opportunistic borrowing, affected interest expense and leverage metrics.

Following the P&HS transaction, management indicated intentions to prioritize debt reduction and reinvestment into patient-focused growth, though official capital allocation policy and dividend decisions should be confirmed by reviewing the latest investor communications.

Stock market information

Key trading facts for omi stock and its transition to Accendra Health:

• Historical ticker and exchange: OMI on the NYSE (historical). The company announced a corporate name change to Accendra Health, Inc. with an expected ticker change to ACH pending required approvals.

• Trading characteristics: Average daily volume and public float for omi stock can vary significantly around corporate events. As of late January 2026, market data providers reported average daily volume in the mid-to-high hundreds of thousands of shares, and a market capitalization in the low hundreds of millions to under one billion dollars range as the market re-priced the company around its new focus. (As of January 24, 2026, per MarketBeat, market capitalization was reported at approximately $720 million and average daily trading volume about 600,000 shares.)

• Analyst coverage and ratings: omi stock historically received coverage from a mix of sell-side analysts and independent equity research outlets. Consensus ratings and price targets have shifted materially after transaction announcements. Investors should reference the latest analyst reports and consensus pulls from market-data providers for up-to-date sentiment.

• Corporate action dates: Important dates for shareholders include the announcement date of the P&HS sale, the effective date of the corporate name change, the ticker switch date, and record dates for any shareholder votes required. These dates are reported in Form 8-K filings and press releases.

For investors seeking to trade the equity after the ticker change, trading venues and market-data terminals will list the current ticker (ACH) once the change becomes effective. For retail investors looking for a custodian or trading platform, consider Bitget for trading access, market data and wallet services relevant to public equities and related instruments.

Governance and management

Governance for the company behind omi stock has historically included an independent board with committees for audit, compensation and governance. Executive leadership changes often accompanied strategic shifts; management appointed to lead the home-health company emphasized operational experience in health services and patient-care models.

Recent executive appointments coincided with the rebranding to Accendra Health and were intended to align leadership competencies with home-based care delivery, reimbursement knowledge and technology-enabled service models.

Regulatory, legal and litigation matters

Like many companies operating in healthcare distribution and patient-care services, the company associated with omi stock has faced routine regulatory oversight, compliance requirements and, at times, litigation. Material legal actions that could affect financial statements are disclosed in SEC filings. Examples of regulatory considerations for patients and investors include reimbursement policy changes, HIPAA and patient-data compliance in home-health offerings, and supply-chain regulatory compliance for medical devices and disposables.

As of the latest public disclosures, the company reported ongoing legal matters in SEC filings where applicable. Investors should consult the Risk Factors and Legal Proceedings sections of the most recent 10-K or 10-Q for the full detail and status updates.

Market strategy and outlook

Following the divestiture and rebrand, Accendra Health’s stated strategic focus centers on being a pure‑play home‑based care and patient-direct provider. Management highlights include:

• Doubling down on scalable DME and respiratory care services.
• Investing in remote-monitoring and telehealth partnerships to enhance chronic-care management at home.
• Expanding clinician-led care coordination to improve outcomes and reduce downstream acute-care utilization.

Analysts tracking omi stock’s transition to Accendra Health see opportunities in aging demographics and rising preference for home-based care, balanced against risks such as reimbursement pressure, integration execution risk and competing home-health providers. Any forecasts or future guidance should be read in the context of management’s official guidance and third-party analyst models.

Investor relations and communications

Shareholders and prospective investors following omi stock should use the company’s investor relations channels for authoritative materials. Typical resources include earnings releases, quarterly/annual reports (Form 10-Q and 10-K), current reports (Form 8-K), investor presentations, and webcasts of earnings calls. The company files these items with the U.S. Securities and Exchange Commission and hosts them on its investor relations page.

Important recurring items and cadence:

• Quarterly earnings reports and conference calls.
• Annual report and proxy statements ahead of shareholder meetings.
• Form 8-K filings for material events, including the P&HS transaction and corporate name/ticker change announcements.

As of January 2026, per the company’s investor-release schedule, shareholders were advised to track Form 8-K filings for final transaction closing details and official dates for the ticker switch to ACH.

Reception and analyst commentary

Market reaction to the strategic pivot and sale was mixed. Some analysts welcomed a clearer strategic focus on patient-direct services, citing potential for improved margin profiles and growth in recurring revenues. Others cautioned about the near-term earnings impact from divestiture charges, transitional costs and the need to deleverage after transaction-related funding events.

Major market reactions to omi stock around the announcement included intraday volatility, analyst note revisions and shifts in consensus price targets. For the most recent analyst consensus ratings and price-target ranges, consult market-data providers and sell-side research summaries that aggregate analyst views.

See also / Disambiguation

Note: "OMI" or the token symbol OMI can refer to different assets. In particular, an unrelated cryptocurrency token uses the symbol OMI (ECOMI). This article focuses exclusively on the NYSE-listed company historically trading as OMI (Owens & Minor) that is transitioning to Accendra Health. Do not confuse the equity omi stock with blockchain tokens or other similarly named entities.

References

Key public sources used to compile this guide include company press releases, SEC filings (Forms 8-K, 10-Q, 10-K), and financial-data and news providers. Examples of authoritative sources and outlets that publish relevant coverage:

• Company press releases and investor relations communications (company Form 8-K filings).
• MarketBeat (stock quotes and market-cap reporting). As of January 24, 2026, MarketBeat reported market-cap and trading-volume metrics referenced above.
• MarketWatch and MarketChameleon (coverage of corporate actions and analyst commentary).
• The Motley Fool and Macrotrends (contextual industry coverage and historical price data).
• TradingEconomics and StockAnalysis (financial metrics and fundamentals).

As required for timeliness: as of January 24, 2026, per MarketBeat and company disclosures, the corporate repositioning and planned ticker change were public and under active completion processes; readers should consult the company’s latest SEC filings for the final, binding dates and figures.

External links

For primary documents and up-to-date filings, investors should consult the company’s official investor relations page and the SEC EDGAR filing system. For trading access and custodial services for public equities, Bitget provides trading, wallets and educational resources that may assist investors in tracking and executing trades after ticker changes.

Notes for editors / Suggested content additions

To keep this entry current, editors should update the article when:

• The P&HS transaction closes and the final cash consideration and retained interests are disclosed.
• The effective date of the corporate name and ticker change to Accendra Health (ACH) is posted.
• Quarterly earnings are released reflecting the post‑transaction financials and pro forma metrics.

Recommended primary sources for future updates: company Form 8‑K(s) for the transaction, the post‑transaction 10‑Q/10‑K filings, and official investor presentations. Avoid mixing data about the OMI cryptocurrency token with the NYSE equity in the same article.

Actionable next step: To monitor omi stock (and the forthcoming ACH ticker) in the market and access trading and custody services, consider opening an account on Bitget and following the company’s official filings and investor presentations for verified updates.